Placeholder Banner

Cancer Research Pioneer Dr. Margaret Foti named 2012 Biotech Humanitarian Honoree

June 20, 2012
Today, BIO named Dr. Margaret Foti, , Ph.D., M.D. (h.c.), CEO of the American Association of Cancer Research, as the 2012 Biotech Humanitarian Honoree.  Dr. Foti was honored for her tireless efforts to improve cancer research, her work as a cancer advocate and her ground-breaking work in the area of team science.

Dr. Foti is also known for her work leading AACR's scientific partnership with Stand Up To Cancer -- a charitable initiative that supports groundbreaking research aimed at getting new cancer treatments to patients in an accelerated time frame.

"Dr. Foti is the epitome of a biotech humanitarian," said Jim Greenwood, president and CEO of BIO.  "Her work with the American Association of Cancer Research has saved countless lives and has advanced cancer research, providing patients diagnosed with cancer with new hope."

During Dr. Foti’s tenure as the CEO of AACR, the organization has developed a dynamic and vibrant membership of over 33,000 members. These members include laboratory, translational and clinical researchers; population scientists; other health care professionals and cancer advocates residing in more than 90 countries.  AACR's vast membership has helped accelerate cancer research and identify areas for collaboration across the globe.

“I am deeply honored and humbled to receive this award from the Biotechnology Industry Organization,” said Margaret Foti. “Today more than ever, cancer researchers are translating fundamental discoveries for the benefit of patients. I passionately believe that enhancing the ability of these dedicated individuals to work together, through programs designed to foster the exchange of knowledge and new ideas among scientists dedicated to cancer research, is instrumental to further advance the field and save more lives.

Dr. Foti also noted that “is also imperative that we share with all members of the general public the extraordinary advances that have been made in cancer research and treatment. This provides new hope to those who have received a diagnosis of cancer and their families, as well as educates everyone about the fact that more work needs to be done to meet the challenges ahead. This award gives me great confidence that the AACR’s hard work is helping advance the understanding of cancer prevention, diagnosis and treatment for the benefit of patients, and that our educational efforts are achieving our goal of broadly disseminating this information relevant to public health.”

BIO established the Biotech Humanitarian Award in 2009 to recognize everyday heroes within the biotechnology community who have helped heal, fuel and feed the planet through their work.

Last year’s Honoree was Dr. Paul Offit, a vaccine advocate who serves as the Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at The Children’s Hospital of Philadelphia. Dr. Offit was presented the Humanitarian Award at the 2011 BIO International Convention in Washington, DC, in recognition of his 25 years spent dedicated to developing RotaTeq, one of the main vaccines currently used to fight rotavirus, a disease that is the leading cause of severe, dehydrating diarrhea in infants and young children.